Showing results (41-50 of 274) with videos related to
Sort By:
Pageof 28
Pharmacogenomics|September 7, 2005
SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnosticsFiona Simpkins, Josephine A Czechowicz, Lance Liotta, et al.International Journal of Oncology|March 29, 2017
Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARPTakuhei Yokoyama, Elise C Kohn, Ethan Brill, et al.Frontiers in Oncology|June 18, 2015
CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian CancerJung-Min Lee, Jane B Trepel, Peter Choyke, et al.Cancer Chemotherapy and Pharmacology|November 24, 2016
Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignanciesCharles A Kunos, Edward Chu, Jan H Beumer, et al.BMC Cancer|April 9, 2010
STAMP alters the growth of transformed and ovarian cancer cellsYuanzheng He, John A Blackford, Elise C Kohn, et al.Cancer|June 21, 2014
The MAPK pathway across different malignancies: a new perspectiveMauricio Burotto, Victoria L Chiou, Jung-Min Lee, et al.Journal of Proteomics|May 17, 2011
Proteomics and biomarkers in clinical trials for drug developmentJung-min Lee, Jasmine J Han, Gary Altwerger, et al.Frontiers in Oncology|July 13, 2019
Radiopharmaceuticals for Persistent or Recurrent Uterine Cervix CancerCharles A Kunos, Jacek Capala, Elise C Kohn, et al.Women'S Health (London, England)|October 7, 2009
The role of proteomics in the diagnosis and treatment of ovarian cancerNana E Tchabo, Elizabeth A Guancial, Josephine A Czechowicz, et al.Lancet (London, England)|April 29, 2014
Ovarian cancerGordon C Jayson, Elise C Kohn, Henry C Kitchener, et al.Pageof 28